Stryker beats Q4 estimates, sells spinal implants biz

Investing.com -- Stryker Corp reported fourth-quarter earnings that beat Wall Street estimates, with earnings of $4.01 per share, ahead of analysts’ expectations of $3.87. Revenue rose to $6.4 billion, slightly ahead of the consensus estimate of $6.36 billion.

For 2025, Stryker (NYSE: SYK) expects earnings of $13.45 to $13.70 per share, compared to the market's forecast of $13.47. The company also projected organic net sales growth of 8% to 9%, citing strong momentum and healthy end markets.

Shares of Stryker were down 1.8% in after-hours trading. The company said it has reached a definitive agreement to sell its U.S. spinal implants business to form a new entity, VB Spine.

“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an independent company," CEO Kevin A. Lobo said.

Stryker announced the retirement of Chief Financial Officer Glenn S. Boehnlein and the promotion of Preston Wells to the role.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Middleby board approves spin-off of food processing unit Midera
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins